Post-doctoral fellow at the Institut du cerveau et de la Moelle Épinière (Sorbonne, Paris), in association with University of São Paulo (Dentistry School of RIbeirão Preto). His actual area of research is the characterization of inflammation in L-DOPA induced dyskinesia, focusing on cannabinoid system. He holds a PhD from the Physiology Department of Ribeirão Preto Medical School and a Master's from the Neuroscience Program of the Fluminense Federal University. Undergraduate in Biomedicine, with emphasis in Scientific Research in the area of Physiology and Pharmacology. He worked with dopaminergic activity in experimental models for Attention Deficit / Hyperactivity Disorder (ADHD), having knowledge of techniques such as neurotransmitter uptake and release, cAMP assay, Western blotting and Binding of receptors, as well as behavioral tests such as elevated plus maze and open field. (Source: Lattes Curriculum)
The loss of dopaminergic (DA) neurons in Parkinson's disease (PD) is accompanied by persistent neuroinflammatory reactions mediated by astrocytes and microglial cells. This process, which is not yet fully characterized, probably perpetuates and amplifies the progression of this disorder. The DA precursor, L-DOPA, remains the most efficient treatment for PD motor symptoms, at least in the …
Dopamine precursor L-DOPA remains the most efficient treatment for Parkinson's disease motor symptoms, at least in the early and middle stages of the disorder. However, chronic treatment with L-DOPA induces several non-motor and motor complications, including L-DOPA-induced dyskinesia (LID). Our hypothesis is that inflammatory mechanisms are also responsible for the LID, since a proinflam…
| 1 / 1 | Ongoing scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 4 |
| Citations | 0 |
| Cit./Article | 0.0 |
| Data from Web of Science | |
GONZALEZ-LIZARRAGA, FLORENCIA L.; PLOPER, DIEGO; AVILA, CESAR L.; SOCIAS, SERGIO B.; DOS-SANTOS-PEREIRA, MAURICIO; MACHIN, BELEN; DEL-BEL, ELAINE; MICHEL, PATRICK PIERRE; PIETRASANTA, I, LIA; RAISMAN-VOZARI, RITA; et al. CMT-3 targets different alpha-synuclein aggregates mitigating their toxic and inflammogenic effects. SCIENTIFIC REPORTS, v. 10, n. 1, NOV 20 2020. Web of Science Citations: 0. (17/24304-0, 18/03482-0, 14/25029-4, 17/14207-7)
DOS SANTOS PEREIRA, MAURICIO; ABREU, GABRIEL HENRIQUE DIAS; ROCCA, JEREMY; HAMADAT, SABAH; RAISMAN-VOZARI, RITA; MICHEL, PATRICK PIERRE; DEL BEL, ELAINE. Contributive Role of TNF-alpha to L-DOPA-Induced Dyskinesia in a Unilateral 6-OHDA Lesion Model of Parkinson's Disease. FRONTIERS IN PHARMACOLOGY, v. 11, JAN 11 2021. Web of Science Citations: 0. (14/25029-4, 18/03482-0, 17/24304-0, 17/14207-7)
DOS-SANTOS-PEREIRA, MAURICIO; GUIMARAES, FRANSCISCO S.; DEL-BEL, ELAINE; RAISMAN-VOZARI, RITA; MICHEL, PATRICK P.. Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-kappa B-dependent signaling and glucose consumption. Glia, v. 68, n. 3, p. 561-573, MAR 2020. Web of Science Citations: 0. (18/03482-0, 14/25029-4, 17/14207-7)
FERREIRA JUNIOR, NILSON CARLOS; DOS-SANTOS-PEREIRA, MAURICIO; GUIMARAES, FRANCISCO SILVEIRA; DEL BEL, ELAINE. Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and l-DOPA-Induced Dyskinesia. NEUROTOXICITY RESEARCH, OCT 2019. Web of Science Citations: 0. (12/17626-7, 14/25029-4, 17/14207-7)
CV Lattes
ORCID